发明名称 COMPOUNDS FOR THE TREATMENT OF WEIGHT LOSS
摘要 A method of treating weight loss due to underlying disease in a patient, the method comprising administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity. A method of treating weight loss due to underlying disease in a patient, the method comprising administering to the patient an effective amount of any one or more of the following: a compound which inhibits the effect of aldosterone such as an aldosterone antagonist; a chymase inhibitor; a cathepsin B inhibitor; a &bgr; receptor blocker; an imidazoline receptor antagonist; a centrally acting α receptor antagonist; a peripherally acting α receptor antagonist; a ganglion blocking agent; a drug that has an effect on cardiovascular reflexes and thereby reduces SNS activity such as an opiate; scopolamine; an endothelin receptor antagonist; and a xanthine oxidize inhibitor. The methods are particularly useful in treating cardiac cachexia.
申请公布号 EP1121111(B1) 申请公布日期 2010.02.10
申请号 EP19990947762 申请日期 1999.10.15
申请人 IMPERIAL INNOVATIONS LIMITED 发明人 ANKER, STEFAN, D.;COATS, ANDREW, J. S.
分类号 A61K31/165;A61K45/00;A61K31/00;A61K31/14;A61K31/167;A61K31/198;A61K31/403;A61K31/404;A61K31/4164;A61K31/4178;A61K31/433;A61K31/439;A61K31/485;A61K31/517;A61K31/56;A61K31/585;A61K31/663;A61K38/00;A61K38/55;A61K41/00;A61K45/06;A61P1/16;A61P3/00;A61P3/10;A61P9/04;A61P9/12;A61P11/00;A61P13/12;A61P31/00;A61P31/18;A61P35/00 主分类号 A61K31/165
代理机构 代理人
主权项
地址